Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BIMEKIZUMAB Cause Incorrect dose administered? 115 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 115 reports of Incorrect dose administered have been filed in association with BIMEKIZUMAB (Bimzelx). This represents 4.7% of all adverse event reports for BIMEKIZUMAB.

115
Reports of Incorrect dose administered with BIMEKIZUMAB
4.7%
of all BIMEKIZUMAB reports
0
Deaths
19
Hospitalizations

How Dangerous Is Incorrect dose administered From BIMEKIZUMAB?

Of the 115 reports, 19 (16.5%) required hospitalization, and 1 (0.9%) were considered life-threatening.

Is Incorrect dose administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BIMEKIZUMAB. However, 115 reports have been filed with the FAERS database.

What Other Side Effects Does BIMEKIZUMAB Cause?

Psoriatic arthropathy (615) Psoriasis (400) Drug ineffective (293) Inappropriate schedule of product administration (238) Injection site pain (225) Product dose omission issue (163) Off label use (160) Oral candidiasis (146) Fatigue (138) Therapy interrupted (138)

What Other Drugs Cause Incorrect dose administered?

TIRZEPATIDE (23,301) ADALIMUMAB (14,000) DUPILUMAB (9,907) RANITIDINE (9,337) INSULIN LISPRO (8,318) ACETAMINOPHEN (5,316) DULAGLUTIDE (5,207) SECUKINUMAB (4,524) INSULIN GLARGINE (3,070) SOMATROPIN (2,772)

Which BIMEKIZUMAB Alternatives Have Lower Incorrect dose administered Risk?

BIMEKIZUMAB vs BIMEKIZUMAB-BKZX BIMEKIZUMAB vs BINIMETINIB BIMEKIZUMAB vs BIOFLAVONOIDS BIMEKIZUMAB vs BIOTIN BIMEKIZUMAB vs BIPERIDEN

Related Pages

BIMEKIZUMAB Full Profile All Incorrect dose administered Reports All Drugs Causing Incorrect dose administered BIMEKIZUMAB Demographics